🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

A study published in JNM and led by Lisa Bodei, MD, PhD and Heiko Schöder found that blood-based biomarkers accurately predict neuroendocrine tumor response to radiopharmaceutical therapy. This study was selected as the featured article of the month: bit.ly/40YblEd

1. For the first SNMMI Correlative Imaging Council case, Lisa Bodei, MD, PhD from Memorial Sloan Kettering Cancer Center presents a case of #PSMARLT where FDG PET, post-treatment SPECT and MRI all play a role in understanding response. Please watch the full video at bit.ly/3Bw5kDm.

Panelists are Dr.(s) Tara Masten, Caterina Ramogida, Danielle Vugts, and Lisa Bodei, MD, PhD!

Amazing Keynote by Lisa Bodei, MD, PhD before tonight’s opening ceremony #ISRS2023

Excited to announce the release of the SNMMI consensus statement on PSMA RLT. We attempted to wrangle with a number of difficult questions about how to use PSMA RLT in clinical practice. Check it out at: jnm.snmjournals.org/content/early/…

New Guideline Alert! Joint #SNMMI #EANM guideline for Lu-177 PSMA-targeted therapy will help practitioners select high-potential patients and prepare for clinical management. Thanks European Association of Nuclear Medicine (EANM)! ow.ly/g7Ls50OKN8q #NuclearMedicine #RPTherapy #ProstateCancer

We will also have a tumor board focused on clinical applications of PSMA-targeted radioligand therapy. What an amazing panel including @morr316 Lisa Bodei, MD, PhD Tuba Kendi Jeremie Calais. See what people think of cases like this. Looking forward to seeing everyone bright and early!

Coming in the fall 2023. So proud to have been a part of this fantastic endeavor! Everything about RPT. Jason Lewis Radiochem MSK The Zeglis Laboratory ☢️

Thank you, Jason!!! Such a fantastic endeavor! Without you and Brian it would never have been possible

The hard copies of "Radiopharmaceutical Therapy" have arrived! Managed to get a pic with my Co-Editors…. The book really is the perfect stocking filler Lisa Bodei, MD, PhD The Zeglis Laboratory ☢️

Join us for episode 6 of the JNM podcast. Moderator Ken Herrmann, MD is joined by Simron Singh, MD and Lisa Bodei, MD, PhD to discuss NETTER-2, the first trial to examine radioligand therapy as a first-line therapy for cancers. Full episode here: youtu.be/whHhKf5fY8I

Reflections on the demand for PSMA- and SSTR-targeted radiopharmaceutical therapies: Why we were wrong (and why we will be right eventually). ow.ly/T40950UYrU2 #RPTherapy #NuclearMedicine #Theranostics Jeremie Calais Lisa Bodei, MD, PhD Johannes Czernin

JNM Podcast Episode 9: PSMA PET: From Adolescence to Adulthood - YouTube youtube.com/watch?v=FD6IWI…

Today is International Women's Day, and SNMMI celebrates all of the trailblazing women in the nuclear medicine field whose expertise, passion, and dedication contribute to the highest standards of patient care.

"I believe that my identity as a woman in this discipline enhances the application of a well-rounded and multifaceted approach to scientific exploration.”

“Being a woman in nuclear medicine comes with the responsibility to recruit, support, and empower more women in this field."

"My leadership journey has reinforced the power of visibility: 'You can't be what you can't see.' I hope my role inspires others to pursue leadership, even if they once doubted their place in this field.”

"Women bring unconditional strength, support, and dedication to whatever role inspires them personally or professionally.”

Green nuclear medicine and theranostics: debate and discussion. ow.ly/pMGa50VgahK #NuclearMedicine #Theranostics #MolecularImaging Ken Herrmann

Pretty packed at the Theranostics in NETs session!